Pharmacists have unique training and expertise in the appropriate use of medications and provide a wide array of patient care services in many different practice settings. These services reduce adverse drug events, improve patient safety, and optimize medication use and health outcomes. Pharmacists contribute to improving patients’ health by providing patient care services as authorized under their scope of practice and facilitated by collaborative practice agreements (CPAs).
According to the Iowa Board of Pharmacy, ‘collaborative pharmacy practice’ means a practice of pharmacy whereby one or more pharmacists provides patient care and drug therapy management services not otherwise permitted to be performed by a pharmacist to patients under a collaborative pharmacy practice agreement with one or more practitioners which defines the nature, scope, conditions, and limitations of the patient care and drug therapy management services to be provided by the pharmacist(s) in order to ensure that a patient achieves the desired outcomes. To review Iowa collaborative practice agreement regulations, please see Iowa Administrative Code 657.39.13 Collaborative Drug Therapy Management.
Effective July 1, 2021, SF 296 broadened the ability of pharmacists and other healthcare providers to enter into collaborative practice agreements (CPAs). In February of 2022, the Iowa Board of Pharmacy finalized rules implementing this legislation.